Literature DB >> 1988510

Antibodies to human T lymphotropic virus type I in a population from the Philippines: evidence for cross-reactivity with Plasmodium falciparum.

C G Hayes1, J P Burans, R B Oberst.   

Abstract

Residents of two areas in the Philippines were tested for human T lymphotropic virus type I (HTLV-I): Napsan, a site endemic for malaria, and a nonmalarious site, Bacolod. By ELISA, 30% of the 1743 Napsan residents were positive. Western blot immunoreactivity with two or more HTLV-I proteins was present in 81% of the ELISA positives; however, there was no reactivity with the env proteins. The frequency of this indeterminate immunoreactivity increased with the malaria antibody titer. None of the 200 Bacolod sera were Western blot immunoreactive. In competitive serologic assays, an HTLV-I lysate blocked the HTLV-I immunoreactivity of the Napsan sera but did not reduce malaria antibody. A Plasmodium falciparum lysate blocked both the HTLV-I and malaria immunoreactivity of the Napsan sera. These results show that indeterminate HTLV-I immunoreactivity can be caused by P. falciparum antibody. Serosurveys conducted in malaria endemic areas should consider this possibility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988510     DOI: 10.1093/infdis/163.2.257

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results.

Authors:  Madoka Kuramitsu; Tsuyoshi Sekizuka; Tadanori Yamochi; Sanaz Firouzi; Tomoo Sato; Kazumi Umeki; Daisuke Sasaki; Hiroo Hasegawa; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Haruka Momose; Kumiko Araki; Masumichi Saito; Kisato Nosaka; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Akihiko Okayama; Kiyonori Miura; Masahiro Satake; Shigeru Saito; Kazuo Itabashi; Kazunari Yamaguchi; Makoto Kuroda; Toshiki Watanabe; Kazu Okuma; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.

Authors:  Sineenart Oota; Kriangsak Chaiwong; Soisaang Pikulsod; Rachanee Khuenkaew; Siriluk Pheakkhuntod; Pornthip Rattajak; Patcharakorn Kramkratok; Carlum Shiu; Sonu Bhatnagar; Tasanee Sakuldamrongpanich
Journal:  Pathog Glob Health       Date:  2018-11-14       Impact factor: 2.894

4.  Noninvasive Detection of Antibodies to Human T-Cell Lymphotropic Virus Types 1 and 2 by Use of Oral Fluid.

Authors:  Timothy Woo; Carolina Rosadas; Samreen Ijaz; Steve Dicks; Jennifer H C Tosswill; Richard S Tedder; Graham P Taylor
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

5.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.

Authors:  F Rouet; L Meertens; G Courouble; C Herrmann-Storck; R Pabingui; B Chancerel; A Abid; M Strobel; P Mauclere; A Gessain
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

7.  Immune response against the exp-1 protein of Plasmodium falciparum results in antibodies that cross-react with human T-cell lymphotropic virus type 1 proteins.

Authors:  K R Porter; J Aguiar; A Richards; B Sandjaya; H Ignatias; H Hadiputranto; R G Ridley; B Takacs; F S Wignall; S L Hoffman; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan.

Authors:  Shih Chien Lu; Bai Hsiun Chen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

9.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

10.  Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia.

Authors:  K R Porter; L Liang; G W Long; M J Bangs; R Anthony; E M Andersen; C G Hayes
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.